Nazione: Stati Uniti
Lingua: inglese
Fonte: NLM (National Library of Medicine)
PROPOFOL (UNII: YI7VU623SF) (PROPOFOL - UNII:YI7VU623SF)
General Injectables and Vaccines, Inc.
INTRAVENOUS
PRESCRIPTION DRUG
Propofol Injectable Emulsion is an IV general anesthetic and sedation drug that can be used as described in the table below. Safety, effectiveness and dosing guidelines for Propofol Injectable Emulsion have not been established for MAC Sedation in the pediatric population; therefore, it is not recommended for this use (see PRECAUTIONS, PEDIATRIC USE). Propofol Injectable Emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. In the Intensive Care Unit (ICU), Propofol Injectable Emulsion can be administered to intubated, mechanically ventilated adult patients to procide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. Propofol Injectable Emulsion is not indicated for use in Pediatric ICU sedation si
Propofol Injectable Emulsion, USP is available as follows: Propofol undergoes oxidative degradation, in the presence of oxygen, and is therefore packaged under nitrogen to eliminate this degradation path. Store between 4° to 25°C (40° to 77°F). Do not freeze. Shake well before use. Do not use if there is evidence of excessive creaming or aggregation, if large droplets are visible, or if there are other forms of phase separation indicating that the stability of the product has been compromised. Slight creaming, which should disappear after shaking, may be visible upon prolonged standing.
Abbreviated New Drug Application
PROPOFOL- PROPOFOL INJECTION, EMULSION GENERAL INJECTABLES AND VACCINES, INC. ---------- PROPOFOL 10 MG PER ML FOR INTRAVENOUS ADMINISTRATION _Strict aseptic technique must alwasy be maintained during handling. Propofol Injectable Emulsion is a single_ _access parenteral product (single patient infusion vial) which contains 0.1% sodium benzoate to inhibit the_ _rate of growth of microorganisms, for up to 12 hours, in the event of accidental exxtrinsic contamination._ _However, Propofol Injectable Emulsion can still support the growth of microorganisms, as it is not an_ _antimicrobially preserved product under USP standards. Do not use if contamination is suspected. Discard_ _unused drug product as directed within the required time limits. There have been reports in which failure to_ _use aseptic technique when handling Propofol Injectable Emulsion was associated with microbial_ _contamination of the product and with fever, infection/sepsis, other life-threatening illness, and/or death._ _There have been reports, in the literature and other public sources, of the transmission of bloodborne_ _pathogens (such as Hepatitis B, Hepatitis C, and HIV) from unsafe injection practices, and use of propofol_ _vials intended for single use on multiple persons. Propofol Injectable Emulsion vials are never to be accessed_ _more than once or used on more than one person._ (See WARNINGS and DOSAGE AND ADMINISTRATION, HANDLING PROCEDURES). DESCRIPTION Propofol Injectable Emulsion, USP is a white or almost white sterile, nonpyrogenic homogenous emulsion containing 10 mg/mL of propofol suitable for intravenous administration. Propofol is chemically described as 2,6-diisopropylphenol. The structural formula is: Propofol is slightly soluble in water and, thus, is formulated in a white, oil-in-water emulsion. The pKa is 11. The octanol/water partition coefficient for propofol is 6761:1 at a pH of 6 to 8.5. In addition to the active component, propofol, the formulation also contains soybean oil (100 mg/mL), glycerin (22.5 mg/mL), egg ph Leggi il documento completo